Observations on serum and red blood cell magnesium changes in treadmill exercise-induced cardiac ischemia

Blood magnesium and potassium alterations with maximal treadmill exercise testing: effects of beta-adrenergic blockade

To test alterations in plasma potassium and magnesium levels with maximal exercise, 15 sedentary, healthy men (mean age 29 years) participated in a double-blind crossover study for 11 weeks with propranolol, atenolol, and placebo. Maximal exercise tests were done at baseline and after placebo and beta-blockade phases. Blood for analysis was collected via indwelling brachial vein angiocatheters at baseline and during and after testing. Plasma potassium and magnesium levels increased at peak exercise with atenolol, propranolol, and placebo. There was no difference among groups in baseline recovery for magnesium (mean 28 minutes, range 24 to 30 minutes). Potassium levels returned to baseline more rapidly (compared with magnesium) in the placebo and atenolol groups (mean 10 minutes); however, recovery time was prolonged with propranolol (26 minutes) compared with placebo and atenolol (p less than 0.01). In conclusion, plasma magnesium and potassium levels increased significantly with maximal exercise and are unaffected by atenolol or propranolol beta-blockade. Propranolol, however (compared with atenolol and placebo), prolongs the time of return to baseline of plasma potassium after exercise.

Erythrocyte, plasma and urinary magnesium in men before and after a marathon

Erythrocyte, plasma and urinary magnesium (Mg2+) concentration was measured in 23 runners before and after a marathon race. Blood samples were drawn from an antecubital vein the morning before the race (baseline), at 3 p.m. (2 h before the start), upon finishing and 12 h later. Compared with the baseline values, the intra-erythrocyte and plasma Mg2+ were decreased (p less than 0.05 or less) immediately after the marathon, from 2.13 +/- 0.16 to 2.02 +/- 0.18 mmol.l-1 cells and from 0.88 +/- 0.06 to 0.81 +/- 0.07 mmol.l-1 respectively. The Mg2+ concentration returned to pre-race values 12 h after completion of the marathon. The urinary Mg2+ excretion rate decreased (p less than 0.001) from 29 +/- 13 to 5 +/- 3 mumol.min-1 during the marathon and increased (p less than 0.05) 12 h after the race to 38 +/- 18 mumol.min-1. It is concluded that the reduction in plasma Mg2+ ion concentration during the marathon cannot be attributed to erythrocyte uptake, urinary excretion or loss in sweat. It is suggested that Mg2+ may be released from erythrocytes into the extracellular fluids during sustained exercise and taken up from these fluids by the adipose cells.